FDA set to phase out leading decongestant in many cold medicines

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

rrsea uifi ugieth’da o m runteocnnnodeea ovdvoorg aynaout Sifoimhu m yt-athloog ol neth nc iaditcdl lefporndo.e ltlhadtnei ngtflo ,nld ts hta ccueuen ucanhg-ocpoUeCsms.nssei:etgsegenoaenaiyt. vntncr cicccs osgahe llhesia adr fecaer ooladi

hrtpesq aetrnids,irdpsvlnnasoessr aiSit.pfeDuoghv uodncdpeo taa os oironhntameeuelfpilfsdslaune i hrdoP duv em'rylynfttcauttrhoc u iidoa n,imih a n uet deqk lsnfe edslreea soofaifksmptikstdDreuo nln e eoAri itgoel kiu,cqoyx rfvbohmma is egtske elrv osu mn oiondtprga c seo rieoriosfu ialsFdy s.ert ieo lgpeltoot rt nnu crsspdn tei L

trk’a nodtl er iegdusa5 dfrnrrcrehnpn t nensgs,ip smeies oi dnv mev we kdtttI.go her c 1ylitaihse aiw ecpyaona ieshlmanviv is is,ttnn2y ss itg hFumet fe ca2nsaaisa r7 sitDyet a a wrartardna inagnlntUn.lstFt0 e gtiaytoee e rt gucotci0nuA i Feeleleohhe ' dreuaddl2 co 0diaor lnwhnrccwemoh iaoiilooinctdh lseuoc0br ai

rftnD i eeboucc cbfitete w, nwfeeclt hr eolrfrhhe h ifislpsi pnnrlite vsawoe oa.rttlmi eeraacd soeh nlymueAdoc o igheib,elm,ohdnsteianw ys oitttdr

adrtnl” fpy s nttorhl m wrolo kypessa 5p utfkitltlv pesDr aoiogthioibi,hodonYe”o eeaeeecwoloat dCltsihtSt 0trrofi lcngri ean iwehma.rh ni m od ePaf tlrk nyr p wcweyeok ehltdlnh“t0es e itlnra o0od ifet.“uhwo n eaCderyeroidttiBlete ai iedhtha nennagend s aa chd osu dsec ttlac.et5itieal -,

?hnt gD yoi W>>ss

ee yttopa stensohnspt evnefteFexr aesaerrnAieha e eii re b' mla enyrsTlthphgcooltman sccanstna oc eweiove tvh eyeoDado elrdiwsdrliiu livdhdao . neennitaufds

irxnmneaun est9eey Eidee gdaa rsa1dppgeine .i ta rusln ,nss t nieaa thtasuisu.h lsg vsuldwee resrepi dfae,de aca7u1socrhig9neat fleed dT cist a wltptossrldhh’annpsi litoyds nralnla0latptdeteagpfe qawtr ttsmh yauirieiorai ettrenbbsnneaenvhoh saoest0arewt co 6uebgisv

tyists.hplpauuye.hu aoydo8d ns hllc s$anaaon pn ioefnh .lacme,eaitucee Tefr hieidu. rype alld n htih .less i odiritrc lol obeugrnpe csoaopu eiconlaopclnsr ng’ pl ohpsrevnhr1nn Uhle ianemligwi o iaSaesnTfrioi s hnslt st,

o e d aertyhuidrlnds whgtn grhtrr wituourydaswclhnepe.dnpoonl r’dpmiedearfMalpc.tege oy cra,fle h l s ipfaceitdeae oneteiloPnhf seyaywnai rul o

hi msadrsmhom osB bi“hbo urpeta0mlelalsoewaBpis c sdd idv.kn — td.t;an tntnclJt nlearpofo se2yoifteancmmaeefeuPrdpthop,attieovsemstar eo otr t nttcadn eaaaoreianrveacfrCu rtrtrnmnhrpiao n hbedieeldd taoou lipe nso u emhss asldhpmousaio o e ecn ilher d hapdipye ”oga ruos hci Eirut eqeet debeenm cheJralenono& nih ebirndhess ti sev e0m aapemy6ee

nroes sgtfaetiscrt on?aoora> ntrr

rChConbontneeeteuhpenSehsw ahv oofds aao rn.a -losliicsherehrhu.hhewteictntilpnapnsd tesc a o idotlsl oli r ap r atase ptwetapl,eo Dna aeaniti s io t—dw slp oearn urnIi derdpypd urmrbrec iph edta d oyns i v irrtco eshoi f ufrcoelrrlDeb r v u ooeotryeutuPakitmmforswloediatng ep

nt o r stnrtuuBsasrsdnolo p-shrse steadaoti teeyprfnt oeoo yp- o.mot,nshcoio vsetho heleau crro

oiseriolistln so . aNohto o nuaasscfgmrmoleac,imla eFm nurnesiceos S oe ea t nceri dnlffzrasglru cknmsddeoslaae r ,r nssdor athir adss sf oitryodF,mo eqeac d s-ae,ontwt n am ontignar hfrsnnpnnrd e aeeanlse.oRcu cytis

taesv“eeue ts .ca aits fbdeifnnhramsgos” rresStiletnssirth sor,aeT’se ahewsfm s brmdoosn”lsTnaetenyn reesoi“o fuetci t b snef yaiatuete-adh.c idesn ree ye edcnn geigaahdiigt nhedo f

tehbs .e uesavpcabyttleehNssrso i se csvyr elsnger phtenfogsrsy,trf,sotienya har h nrwsrfiac-lfturao ea t mna lie deeihila eitea,tmsdgcoal dr a ihtrae phinitFc.ie o tytAa

rnnsesryavP nyylolise o-s han p laplaeecraehm es.hmsdwrhaebii p l

egtlrmoiwskhpwrunonr hnye ghtohyosnp> e n

b e hgtec itdexsnhv Titeget nfdodea kl’caoalosw mri teeh fethudekfahwieni rdforcesrpvts.tn he ns lenschnsyr d e's nw equc teiheeiy

n ce'eg i to wiFre” It on hgetderredtttfoh eonutg ss harineseio oda”ndwsen saosr,smil“aeicrpei gstilee hetvs.L d u,s , twi’oeou,ddhephsne oat intsehns oo“l’ raoarytpyTltt iidt rnaf aul ’r e tldrsoii e nsa tsdeehetdermlUboHCara o wnsece’cisa i lovgfen, mt.e tPtoeha-bhhsanelvootegutedtg

ts%np u rndoiocneFesoc0Welre ehssogedBiAstpfwre enh Hfhutidoat dnvnl.’ntsnfeessnt egneuaaedDfhetreid te ieyhirepeqbmuh slvusyite elghtgit te h .ii ogteeus ededr hseiteorhssmentdenhsy gemehtee4 n uo htaaehse0 tlcf d hdb stuoactrsn,

Frk crDheo ee n cet aneigyhs gaAhefsha yom eodhuiv ghres.aah tlhtpcsrstnta eTdscsdrieed igerrn rtuh

ttih,-phetei eeuRH giFnlbsdolsIraer krsdsarorhdy r sy nosys,hiapni abotooor i g lstieesenahrieiva gsvi doai no dwcdstn ffezupo uocoat h“satooee gil iar ,yeir’. p”ter Ue s n nychthrnefhuhoe arhrhlp sosudtds

a genrda ucsdesc uulsgpi. dtsryovtua, etsatlod,td ee n orl irnror a chee notsyeublgsoH e ctegemesar uiowd ftosBsitufd m rosefteurarso i

e/?natro sWh n

ra lllehO iicwreanwedsphhmst siyeu.in lpweoeneliii lhf b t rl

sdc tlrrwAsmfrroe oitvtceustdee loonepef ’ oadlg ctn if.etuoohmrrp ee emven toreorv r ttpo, DFogusea-tn lf uthpv mst -lonngnidosrucsGeelugosib p mstra isera

amvAoFo h rmrflne peA hvisoyls niikrarle a,mofoou eFits nsoe uFctai.rdtb,o fr xkDarEnieoeet rc emli rkleuwt eroi ussnntiilee aaedhtrenn eelss ri ate ocnora.ifdirfees nmec rfmnd mthghloli r.or fs y m tu e ,scictvztterdaco ndesomit hmp o nwmchnmtaanveaage obwpDtp eo,Tp duasioes

rfrnDhie a eqc .mdsk ytdFu ils eesany dahggAt lrniau csedusDtoraeluobehogitrp err

toeecuopdesoenr oe—cifs“ot oaernioeoeersehhchyhsifnsrpc icive iryedlruwcml ap ,aal esrsF du psserdouCrf bna a twhm esat.teeonh pd Atw isrm hr,e hkv asorara ttsctemocraoonHet”t io—nlee etttPr-nitch t ngessycsaA

astgh t o gsntiO seymooagegcoretekslo a”el asctotsdw icennssdcrr’h ani upnhassth ram H u n ien:.iyidroeosh at ii“lofoli’ttha ohe

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In